RATIONALE: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare autoimmune vasculitis characterized by severe asthma, eosinophilia, and anti-neutrophil cytoplasmic autoantibody (ANCA) positivity in similar to 40% of patients. gamma delta T cells are unconventional lymphocytes that bridge innate and adaptive immunity and are increasingly implicated in autoimmunity through early IL-17A secretion and pro-inflammatory activation. Their role in EGPA, however, remains unclear. OBJECTIVE: The objective of this study was to define gamma delta T cell frequency, phenotype and cytokine secretion in EGPA compared with asthma and healthy controls. METHODS: Peripheral blood and sputum were collected from EGPA (n = 20), asthma (n = 18) and healthy controls (n = 54). Flow cytometry assessed CD4(+), CD8(+) and gamma delta T cell subsets, PD-1, EOMES and T-bet expression, and cytokine production. RESULTS: Peripheral gamma delta T cells were significantly reduced in EGPA and asthma versus healthy controls (p < 0.01). EGPA patients showed increased PD-1 expression on gamma delta T cells (p < 0.01) and a higher proportion of IL-17A-producing gamma delta T cells (p < 0.05). IL-17A production by CD4+ and CD8+ T cells was similar across groups. gamma delta T cells were not linked to IL-5-driven eosinophilic inflammation, and no associations were found between gamma delta T cell profiles and clinical vasculitis. A trend toward higher serum IL-17A in EGPA patients with vasculitis was observed (p = 0.0747). T cell subsets did not correlate with serum or sputum ANCA levels. CONCLUSION: EGPA is associated with peripheral gamma delta T cell dysregulation characterized by reduced frequency, elevated IL-17A secretion, and increased PD-1 expression, independent of IL-5-driven eosinophilic inflammation. These findings suggest a potential role for gamma delta T cells in EGPA pathogenesis and warrant further mechanistic investigation.
Objectives: Major depressive disorder (MDD) is a leading cause of global disability and is notably prevalent in older adults. Deep transcranial magnetic stimulation (dTMS), specifically the H1-coil targeting the lateral prefrontal cortex, is approved for adults with treatment-resistant MDD and has shown promise in seniors. However, substantive proportions do not respond to the H1-coil and other H-coils, targeting different brain regions implicated in MDD, may also offer therapeutic benefits. The current study examined the feasibility and tolerability of the H4-coil and H7-coil designs in seniors with MDD for the first time. Materials and Methods: Participants were 21 older adults with moderate-to-severe treatment-resistant MDD randomized to 20 sessions of H4-coil or H7-coil dTMS for four weeks. Primary outcomes were feasibility (protocol completion) and tolerability (frequency of adverse events). Secondary outcomes were depression, anxiety, cognition, sleep, and somatic complaints, and coil differences. Results: Intention-to-treat protocol completion rates were 86.8% for the H4-coil and 98% for the H7-coil. Both treatments were generally well-tolerated with low rates of AEs and no evidence of negative cognitive effects. There was a significant reduction in depression (F(4,68) = 46.54, p < 0.0000001, h2 = 0.73), but no significant coil differences. Both treatments also led to significant reductions in anxiety and somatic complaints. Conclusion: This study provides evidence supporting the feasibility and tolerability of the H4-coil and H7-coil in seniors with MDD, with promising evidence of therapeutic benefits. The findings support future sham-controlled designs to formally evaluate clinical efficacy. Clinical Trial Registration: The Clinicaltrials.gov registration number for the study is NCT05855850. (Am J Geriatr Psychiatry 2026; 34:41-56)
In prednisone-dependent severe asthma, uncontrolled sputum eosinophilia is associated with increased numbers of group 2 innate lymphoid cells (ILC2s). These cells represent a relatively steroid-insensitive source of interleukin-5 (IL-5) and IL-13 and are considered critical drivers of asthma pathology. The abundance of ILC subgroups in severe asthma with neutrophilic or mixed granulocytic (both eosinophilic and neutrophilic) airway inflammation, prone to recurrent infective exacerbations, remains unclear. Here, we found by flow cytometry that sputum ILC3s are increased in severe asthma with intense airway neutrophilia, whereas equivalently raised sputum ILC2s and ILC3s were found in severe asthma with mixed granulocytic inflammation. Unbiased clustering analyses identified an “intermediate-ILC2” population displaying markers of both ILC2s (prostaglandin D 2 receptor 2; CRTH2, IL-5, and IL-13) and ILC3s (c-kit and IL-17A) that were most abundant in severe asthma with mixed granulocytic airway inflammation. Intermediate ILC2s correlated with airway neutrophilia and were associated with increased amounts of IL-1β and IL-18 in sputum supernatants. Coculture of sort-purified canonical ILC2s with IL-1β and IL-18 in vitro up-regulated c-kit and IL-17A as well as gene expression profiles related to both type 2 and type 17 inflammatory pathways. Together, we have identified an intermediate-ILC2 phenotype in the airways of individuals with severe mixed granulocytic asthma, representing a candidate therapeutic target for controlling neutrophilic airway inflammation.
Purpose of reviewTo describe the recent advances in the pathobiology and treatment of mucus hypersecretion in asthma, a critical factor contributing to airway obstruction, inflammation, and impaired lung function.Recent findingsSignificant progress has been made in understanding how mucin protein regulation, mucus viscosity, and adhesion are affected by cytokine-driven inflammation, especially interleukin-13, and defects in ion transport mechanisms. Advances in imaging techniques, such as multidetector computed tomography (MDCT) and hyperpolarized gas MRI, allow for a more precise assessment of mucus plugging and associated ventilation defects. Emerging therapies, including biologicals targeting type-2 (T2) inflammation, and novel mucolytics aimed at modifying mucus properties and secretion, offer promising effects in reducing mucus in severe asthmatics.SummaryThe growing understanding of mucus biology and the development of advanced imaging and therapeutic strategies could significantly improve the management of mucus-related complications in asthma. By targeting mucus characteristics, these findings support future approaches to reduce airway obstruction, enhance lung function, and improve clinical outcomes in patients with severe asthma. A deeper understanding of the glycobiology of mucus is critical to develop new therapies.
Gang members face a paradox: while they may join a gang for protection from violence, they are actually more likely to be victimized than non-gang members. Although it is known that gang affiliation increases the risk of violence perpetration and victimization, little is understood about the factors within gangs that influence these risks. This study examines the relationship between violent perpetration and victimization within the context of gang networks. Using 20 years of police data, we mapped the incidents of violent victimization and perpetration among 1587 Haitian street gang members and their affiliates in Montreal, Canada. Our results show that violence occurs in clusters within these groups and that victimization and perpetration are more likely to happen in the same locations within the network. Regression models revealed that victimization was strongly related to: (1) having committed violence, (2) having more violent perpetrators in one's entourage, and (3) having more victims in one's entourage. These three effects were interdependent, creating a mutual aggravation effect: members who had perpetrated high levels of violence, high levels of victimization in their network, and who had violent peers were 15 times more victimized than members who were not directly or indirectly involved in violence. The structure of peer relationships was also important. Denser networks provided some protection against victimization, but this was dependent on members' own level of violence. Violent perpetrators did not benefit from the protection offered by a close-knit network. Our findings show that violence within gangs is not equally distributed and is concentrated in certain areas of the network. Perpetration and victimization are linked, and the local density of the network can reduce the impact of violence in the network. Thus, the idea that gangs can provide protection may not be as paradoxical as it seems. In tightly knit groups, and for members not directly involved in violence, gang affiliation did not increase violence risk. This understanding may improve targeted interventions to prevent both the experience and commission of violence.